Search for Clinical Trial Results
Familial Cold Autoinflammatory Syndrome - 17 Studies Found
Status | Study |
Completed |
Study Name: Rilonacept for Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS) Condition:
|
Completed |
Study Name: The CAP-2 Trial: Effect of Direct Pulp Capping Versus Partial Pulpotomy Condition: Dental Pulp Exposure Date: 2005-09-13 Interventions:
|
Completed |
Study Name: Vaccine Therapy in Treating Patients With Refractory Stage IV Cancer Condition: Unspecified Adult Solid Tumor, Protocol Specific Date: 2003-04-07 Interventions: Biological: CEA peptide 1-6D CAP-1(6D) peptide-pulsed, matured, autologous human DC produced by the Aast |
Terminated |
Study Name: Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract Condition:
|
Completed |
Study Name: The Safety and Efficacy of Canakinumab in Patients Aged 4 Years or Older Diagnosed With Cryopyrin-associated Periodic Syndromes (CAPS) in Canada Condition: Cryopyrin Associated Periodic Syndrome Date: 2010-03-25 Interventions: Drug: canakinumab (company code: ACZ885D) |
Completed |
Study Name: Clinical Outcomes and Safety: A Registry Study of Ilaris (Canakinumab) Patients Condition:
|
Terminated |
Study Name: HL2351 CAPS Phase II Study Condition: Cryopyrin‑Associated Periodic Syndromes (CAPS) Date: 2016-05-10 Interventions: Drug: HL2351 The dose will be adjusted based on disease activities |